| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A p53-JAK-STAT connection involved in myeloproliferative neoplasm pathogenesis and progression to secondary acute myeloid leukemia
|
Goyal, Harsh
|
|
|
42 |
C |
p.
|
article
|
| 2 |
Current and future therapies for myelofibrosis
|
Asher, Samir
|
|
|
42 |
C |
p.
|
article
|
| 3 |
Current management strategies for polycythemia vera and essential thrombocythemia
|
Guglielmelli, Paola
|
|
|
42 |
C |
p.
|
article
|
| 4 |
Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex map
|
Shallis, Rory M.
|
|
|
42 |
C |
p.
|
article
|
| 5 |
Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice
|
Lee, Joe
|
|
|
42 |
C |
p.
|
article
|
| 6 |
Germline genetic factors in the pathogenesis of myeloproliferative neoplasms
|
Bellanné-Chantelot, Christine
|
|
|
42 |
C |
p.
|
article
|
| 7 |
Management of challenging myelofibrosis after JAK inhibitor failure and/or progression
|
Scherber, Robyn M.
|
|
|
42 |
C |
p.
|
article
|
| 8 |
Myeloproliferative neoplasms (MPNs)
|
Godfrey, Anna L.
|
|
|
42 |
C |
p.
|
article
|
| 9 |
Prognostic models in the myeloproliferative neoplasms
|
Grinfeld, Jacob
|
|
|
42 |
C |
p.
|
article
|
| 10 |
Role of inflammation in the biology of myeloproliferative neoplasms
|
Koschmieder, Steffen
|
|
|
42 |
C |
p.
|
article
|
Journal description